{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T21:24:16Z","timestamp":1793049856101,"version":"4.5.0"},"reference-count":149,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,7,10]],"date-time":"2019-07-10T00:00:00Z","timestamp":1562716800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["307155\/2017-0"],"award-info":[{"award-number":["307155\/2017-0"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2017\/04724-4"],"award-info":[{"award-number":["2017\/04724-4"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2017\/14035-1"],"award-info":[{"award-number":["2017\/14035-1"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2018\/14158-9"],"award-info":[{"award-number":["2018\/14158-9"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008398","name":"Villum Fonden","doi-asserted-by":"publisher","award":["00025302"],"award-info":[{"award-number":["00025302"]}],"id":[{"id":"10.13039\/100008398","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2019.01598","type":"journal-article","created":{"date-parts":[[2019,7,10]],"date-time":"2019-07-10T00:38:47Z","timestamp":1562719127000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":123,"title":["History of Envenoming Therapy and Current Perspectives"],"prefix":"10.3389","volume":"10","author":[{"given":"Manuela B.","family":"Pucca","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felipe A.","family":"Cerni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahel","family":"Janke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erick","family":"Berm\u00fadez-M\u00e9ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Line","family":"Ledsgaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 E.","family":"Barbosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas H.","family":"Laustsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2019,7,10]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"5270","DOI":"10.2174\/1381612822666160623073438","article-title":"From fangs to pharmacology: the future of snakebite envenoming therapy","volume":"22","author":"Laustsen","year":"2016","journal-title":"Curr Pharm Des."},{"key":"B2","doi-asserted-by":"publisher","first-page":"17063","DOI":"10.1038\/nrdp.2017.79","article-title":"Snakebite envenoming","volume":"3","author":"Guti\u00e9rrez","year":"2017","journal-title":"Nat Rev Dis Primer."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1055\/s-0029-1207589","article-title":"\u00dcber das Zustandekommen der Diphtherie- Immunit\u00e4t und der Tetanus-Immunit\u00e4t bei Thieren","volume":"16","author":"Behring","year":"1890","journal-title":"Dtsch Med Wochenschr."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1055\/s-0029-1207609","article-title":"Untersuchungen uber das Zustandekommen der Diphtherie-Immunitat and der Tetanus-Immunitat bei Thieren","volume":"16","author":"Behring","year":"1890","journal-title":"Dtsch Med Wochenschr."},{"key":"B5","doi-asserted-by":"crossref","unstructured":"BehringE\n          LeipzigG. ThiemeDie Geschichte der Diphtherie; mit besonderer Ber\u00fccksichtigung der Immunit\u00e4tslehre.1893","DOI":"10.5962\/bhl.title.29160"},{"key":"B6","doi-asserted-by":"publisher","first-page":"e00117","DOI":"10.1128\/mBio.00117-17","article-title":"Remembering Emil von Behring: from Tetanus Treatment to Antibody Cooperation with Phagocytes","volume":"8","author":"Kaufmann","year":"2017","journal-title":"Mbio."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1898","DOI":"10.1055\/s-0041-110248","article-title":"On the awarding of the first Nobel Prize for physiology or medicine to Emil von Behring","volume":"140","author":"Hansson","year":"2015","journal-title":"Dtsch Med Wochenschr."},{"key":"B8","unstructured":"YongE\n          The Absurdity of the Nobel Prizes in Science2017"},{"key":"B9","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1055\/s-0029-1206682","article-title":"Experimentelle untersuchungen \u00fcber immunit\u00e4t","volume":"17","author":"Ehrlich","year":"1891","journal-title":"Dtsch Med Wschr."},{"key":"B10","unstructured":"Milestone 2: the many sides of Paul Ehrlich\n            BordonY\n          10.1038\/ni.3601Nat Milest Antib.2016"},{"key":"B11","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1159\/000149583","article-title":"The contributions of Paul Ehrlich to pharmacology: a tribute on the occasion of the centenary of his Nobel Prize","volume":"82","author":"Bosch","year":"2008","journal-title":"Pharmacology."},{"key":"B12","unstructured":"1908"},{"key":"B13","unstructured":"19145813The Scientist Magazine1900"},{"key":"B14","volume-title":"Die Wertbemessung des Diphtherieheilserums und deren theoretische Grundlagen","author":"Ehrlich","year":"1897"},{"key":"B15","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1084\/jem.69.1.119","article-title":"An electrophoretic study of immune sera and purified antibody preparations","volume":"69","author":"Tiselius","year":"1939","journal-title":"J Exp Med."},{"key":"B16","doi-asserted-by":"publisher","first-page":"2643","DOI":"10.1021\/ja01867a018","article-title":"A theory of the structure and process of formation of antibodies","volume":"62","author":"Pauling","year":"1940","journal-title":"J Am Chem Soc."},{"key":"B17","unstructured":"Milestone 3: searching for the antibody producers\n            KugelbergE\n          10.1038\/ni.3602Nat Milest Antib.2016"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1038\/1811419a0","article-title":"Antibody production by single cells","volume":"181","author":"Nossal","year":"1958","journal-title":"Nature."},{"key":"B19","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1042\/bj0730119","article-title":"The hydrolysis of rabbit \u03b3-globulin and antibodies with crystalline papain","volume":"73","author":"Porter","year":"1959","journal-title":"Biochem J."},{"key":"B20","doi-asserted-by":"publisher","first-page":"3155","DOI":"10.1021\/ja01521a071","article-title":"Dissociation of \u03b3-globulin","volume":"81","author":"Edelman","year":"1959","journal-title":"J Am Chem Soc."},{"key":"B21","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1073\/pnas.63.1.78","article-title":"The covalent structure of an entire \u03b3G immunoglobulin molecule","volume":"63","author":"Edelman","year":"1969","journal-title":"Proc Natl Acad Sci USA."},{"key":"B22","doi-asserted-by":"publisher","first-page":"5140","DOI":"10.1073\/pnas.74.11.5140","article-title":"Three-dimensional structure of an intact human immunoglobulin","volume":"74","author":"Silverton","year":"1977","journal-title":"Proc Natl Acad Sci USA."},{"key":"B23","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1084\/jem.132.2.211","article-title":"An analysis of the sequences of the variable regions of Bence Jones proteins and myeloma light chains and their implications for antibody complementarity","volume":"132","author":"Wu","year":"1970","journal-title":"J Exp Med."},{"key":"B24","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1016\/S0140-6736(61)90693-6","article-title":"Immunological function of the thymus","volume":"2","author":"Miller","year":"1961","journal-title":"Lancet Lond Engl."},{"key":"B25","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1073\/pnas.66.2.337","article-title":"Evidence for control of synthesis of the varible regions of the heavy chains of immunoglobulins G and M by the same gene","volume":"66","author":"Wang","year":"1970","journal-title":"Proc Natl Acad Sci USA."},{"key":"B26","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1016\/0019-2791(71)90454-X","article-title":"Enzyme-linked immunosorbent assay (ELISA). Quantitative assay of immunoglobulin G","volume":"8","author":"Engvall","year":"1971","journal-title":"Immunochemistry."},{"key":"B27","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1038\/icb.1997.10","article-title":"A brief history of the discovery of the immunoglobulins and the origin of the modern immunoglobulin nomenclature","volume":"75","author":"Black","year":"1997","journal-title":"Immunol Cell Biol."},{"key":"B28","unstructured":"PrakashMS\n          Nature Milestones: Antibodies"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1016\/S0041-0101(99)00086-0","article-title":"Doctor Albert Calmette 1863-1933: founder of antivenomous serotherapy and of antituberculous BCG vaccination","volume":"37","author":"Hawgood","year":"1999","journal-title":"Toxicon."},{"key":"B30","first-page":"160","article-title":"\u00c9tude exp\u00e9rimentale du venin de Naja tripudians ou cobra capel et expos\u00e9 d'une m\u00e9thode de neutralization de ce venin dans l'organisme","volume":"6","author":"Calmette","year":"1982","journal-title":"Ann Inst Pasteur."},{"key":"B31","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1113\/jphysiol.1887.sp000253","article-title":"Experiments on the preventive inoculation of rattlesnake venom","volume":"8","author":"Sewall","year":"1887","journal-title":"J Physiol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.toxicon.2018.05.008","article-title":"The history of antivenoms development: beyond Calmette and Vital Brazil","volume":"150","author":"Squaiella-Baptist\u00e3o","year":"2018","journal-title":"Toxicon."},{"key":"B33","first-page":"120","article-title":"L'immunisation artificielle des animaux contre le venin des serpents, et la th\u00e9rapeutique exp\u00e9rimentale des morsures venimeuses","volume":"46","author":"Calmette","year":"1894","journal-title":"Comptes Rendus Hebd S\u00e9ances M\u00e9m Soci\u00e9t\u00e9 Biol."},{"key":"B34","first-page":"288","article-title":"Att\u00e9nuation du venin de vip\u00e8re par la chaleur et vaccination du cobaye contre ce venin","volume":"118","author":"Phisalix","year":"1894","journal-title":"Comptes Rendus Hebd S\u00e9ances L'acad\u00e9mie Sci."},{"key":"B35","first-page":"7","article-title":"History of the primordia of snake-bite accident serotherapy","volume":"49","author":"Vital Brazil","year":"1987","journal-title":"Mem Inst Butantan."},{"key":"B36","doi-asserted-by":"publisher","first-page":"1805","DOI":"10.1136\/bmj.2.1981.1805","article-title":"The curative value of Calmette's antivenomous serum in the treatment of inoculations with the poisons of Australian snakes","volume":"2","author":"Martin","year":"1898","journal-title":"Br Med J."},{"key":"B37","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/0041-0101(92)90851-U","article-title":"Pioneers of anti-venomous serotherapy: Dr. Vital Brazil (1865-1950)","volume":"30","author":"Hawgood","year":"1992","journal-title":"Toxicon."},{"key":"B38","first-page":"275","article-title":"Contribution \u00e0 l'\u00e9tude du venin des serpents, immunization des animaux et traitement de l'envenimation","volume":"8","author":"Calmette","year":"1894","journal-title":"Ann Inst Pasteur."},{"key":"B39","first-page":"111","article-title":"Sur la propri\u00e9t\u00e9 du sang des animaux vaccin\u00e9s contre le venin de vip\u00e8re","volume":"46","author":"Phisalix","year":"1894","journal-title":"Comptes Rendus Hebd S\u00e9ances M\u00e9m Soci\u00e9t\u00e9 Biol."},{"key":"B40","first-page":"225","article-title":"Contribution \u00e0 l'\u00e9tude des venins, des toxins et des serums antitoxiques","volume":"9","author":"Calmette","year":"1895","journal-title":"Ann Inst Pasteur."},{"key":"B41","volume-title":"Le Venin des Serpents, Physiologie de L'envenimation, Traitement des Morsures Venimeuses par le S\u00e9rum des Animaux Vaccin\u00e9s","author":"Calmette","year":"1986"},{"key":"B42","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.toxicon.2015.11.013","article-title":"Understanding and confronting snakebite envenoming: the harvest of cooperation","volume":"109","author":"Guti\u00e9rrez","year":"2016","journal-title":"Toxicon."},{"key":"B43","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1016\/j.toxicon.2006.08.001","article-title":"Twentieth century toxinology and antivenom development in Australia","volume":"48","author":"Winkel","year":"2006","journal-title":"Toxicon."},{"key":"B44","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.toxicon.2012.12.015","article-title":"History of scorpion antivenom: one Arizonan's view","volume":"69","author":"Boyer","year":"2013","journal-title":"Toxicon."},{"key":"B45","unstructured":""},{"key":"B46","unstructured":""},{"key":"B47","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.tree.2012.10.020","article-title":"Complex cocktails: the evolutionary novelty of venoms","volume":"28","author":"Casewell","year":"2013","journal-title":"Trends Ecol Evol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1002\/pmic.200300628","article-title":"Snake venomics: characterization of protein families in Sistrurus barbouri venom by cysteine mapping, N-terminal sequencing, and tandem mass spectrometry analysis","volume":"4","author":"Ju\u00e1rez","year":"2004","journal-title":"Proteomics."},{"key":"B49","doi-asserted-by":"publisher","first-page":"3530","DOI":"10.1039\/C6MB00516K","article-title":"Advances in venomics","volume":"12","author":"Oldrati","year":"2016","journal-title":"Mol Biosyst."},{"key":"B50","doi-asserted-by":"publisher","first-page":"E19","DOI":"10.3390\/ht7030019","article-title":"Venomics: a mini-review","volume":"7","author":"Wilson","year":"2018","journal-title":"High Throughput."},{"key":"B51","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.nbt.2017.05.005","article-title":"Guiding recombinant antivenom development by omics technologies","volume":"45","author":"Laustsen","year":"2018","journal-title":"New Biotechnol."},{"key":"B52","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.toxicon.2018.05.009","article-title":"The snakebite problem and antivenom crisis from a health-economic perspective","volume":"150","author":"Habib","year":"2018","journal-title":"Toxicon."},{"key":"B53","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1093\/trstmh\/trv088","article-title":"Antivenom shortage is not circumstantial but structural","volume":"109","author":"Chippaux","year":"2015","journal-title":"Trans R Soc Trop Med Hyg."},{"key":"B54","doi-asserted-by":"publisher","first-page":"e0007059","DOI":"10.1371\/journal.pntd.0007059","article-title":"Strategy for a globally coordinated response to a priority neglected tropical disease: snakebite envenoming","volume":"13","author":"Williams","year":"2019","journal-title":"PLoS Negl Trop Dis."},{"key":"B55","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1038\/171737a0","article-title":"Molecular structure of nucleic acids: a structure for deoxyribose nucleic acid","volume":"171","author":"Watson","year":"1953","journal-title":"Nature."},{"key":"B56","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1038\/227561a0","article-title":"Central dogma of molecular biology","volume":"227","author":"Crick","year":"1970","journal-title":"Nature."},{"key":"B57","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1126\/science.139.3554.461","article-title":"On the genetic code","volume":"139","author":"Crick","year":"1963","journal-title":"Science."},{"key":"B58","first-page":"138","article-title":"On protein synthesis","volume":"12","author":"Crick","year":"1958","journal-title":"Symp Soc Exp Biol."},{"key":"B59","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1038\/1921227a0","article-title":"General nature of the genetic code for proteins","volume":"192","author":"Crick","year":"1961","journal-title":"Nature."},{"key":"B60","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1038\/2171110a0","article-title":"DNA restriction enzyme from E. coli","volume":"217","author":"Meselson","year":"1968","journal-title":"Nature."},{"key":"B61","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/0022-2836(70)90149-X","article-title":"A restriction enzyme from Hemophilus influenzae","volume":"51","author":"Smith","year":"1970","journal-title":"J Mol Biol."},{"key":"B62","doi-asserted-by":"publisher","first-page":"2904","DOI":"10.1073\/pnas.69.10.2904","article-title":"Biochemical method for inserting new genetic information into DNA of simian virus 40: circular SV40 DNA molecules containing lambda phage genes and the galactose operon of Escherichia coli","volume":"69","author":"Jackson","year":"1972","journal-title":"Proc Natl Acad Sci USA."},{"key":"B63","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1016\/0006-291X(72)90852-2","article-title":"Nucleotide sequence analysis of DNA: IX. Use of oligonucleotides of defined sequence as primers in DNA sequence analysis","volume":"48","author":"Padmanabhan","year":"1972","journal-title":"Biochem Biophys Res Commun."},{"key":"B64","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1038\/newbio236198a0","article-title":"Nucleotide sequence analysis of DNA","volume":"236","author":"Wu","year":"1972","journal-title":"Nature New Biol."},{"key":"B65","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1038\/237082a0","article-title":"Nucleotide sequence of the gene coding for the bacteriophage MS2 coat protein","volume":"237","author":"Min Jou","year":"1972","journal-title":"Nature."},{"key":"B66","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1038\/256495a0","article-title":"Continuous cultures of fused cells secreting antibody of predefined specificity","volume":"256","author":"K\u00f6hler","year":"1975","journal-title":"Nature."},{"key":"B67","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1038\/312643a0","article-title":"Production of functional chimaeric mouse\/human antibody","volume":"312","author":"Boulianne","year":"1984","journal-title":"Nature."},{"key":"B68","doi-asserted-by":"publisher","first-page":"6851","DOI":"10.1073\/pnas.81.21.6851","article-title":"Chimeric human antibody molecules: mouse antigen-binding domains with human constant region domains","volume":"81","author":"Morrison","year":"1984","journal-title":"Proc Natl Acad Sci USA."},{"key":"B69","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1126\/science.4001944","article-title":"Filamentous fusion phage: novel expression vectors that display cloned antigens on the virion surface","volume":"228","author":"Smith","year":"1985","journal-title":"Science."},{"key":"B70","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/0022-2836(86)90171-3","article-title":"Cell surface exposure of the outer membrane protein OmpA of Escherichia coli K-12","volume":"188","author":"Freudl","year":"1986","journal-title":"J Mol Biol."},{"key":"B71","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1101\/SQB.1986.051.01.032","article-title":"Specific enzymatic amplification of DNA in vitro: the polymerase chain reaction","volume":"1","author":"Mullis","year":"1986","journal-title":"Cold Spring Harb Symp Quant Biol."},{"key":"B72","doi-asserted-by":"crossref","DOI":"10.1385\/1592593844","volume-title":"PCR Protocols","author":"Bartlett","year":"2003"},{"key":"B73","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1038\/321522a0","article-title":"Replacing the complementarity-determining regions in a human antibody with those from a mouse","volume":"321","author":"Jones","year":"1986","journal-title":"Nature."},{"key":"B74","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1038\/348552a0","article-title":"Phage antibodies: filamentous phage displaying antibody variable domains","volume":"348","author":"McCafferty","year":"1990","journal-title":"Nature."},{"key":"B75","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1038\/nbt1126","article-title":"Selecting and screening recombinant antibody libraries","volume":"23","author":"Hoogenboom","year":"2005","journal-title":"Nat Biotechnol."},{"key":"B76","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1080\/19420862.2018.1556465","article-title":"Antibodies to watch in 2019","volume":"11","author":"Kaplon","year":"2019","journal-title":"MAbs"},{"key":"B77","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1038\/363446a0","article-title":"Naturally occurring antibodies devoid of light chains","volume":"363","author":"Hamers-Casterman","year":"1993","journal-title":"Nature."},{"key":"B78","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/S1389-0352(01)00021-6","article-title":"Single domain camel antibodies: current status","volume":"74","author":"Muyldermans","year":"2001","journal-title":"J Biotechnol."},{"key":"B79","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1093\/protein\/7.9.1129","article-title":"Sequence and structure of VH domain from naturally occurring camel heavy chain immunoglobulins lacking light chains","volume":"7","author":"Muyldermans","year":"1994","journal-title":"Protein Eng."},{"key":"B80","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1056\/NEJMoa1806311","article-title":"Caplacizumab treatment for acquired thrombotic thrombocytopenic purpura","volume":"380","author":"Scully","year":"2019","journal-title":"N Engl J Med."},{"key":"B81","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1038\/374168a0","article-title":"A new antigen receptor gene family that undergoes rearrangement and extensive somatic diversification in sharks","volume":"374","author":"Greenberg","year":"1995","journal-title":"Nature."},{"key":"B82","doi-asserted-by":"publisher","first-page":"15","DOI":"10.4161\/19420862.2015.989032","article-title":"Structural insights and biomedical potential of IgNAR scaffolds from sharks","volume":"7","author":"Zielonka","year":"2015","journal-title":"MAbs."},{"key":"B83","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/ng0594-13","article-title":"Antigen\u2013specific human monoclonal antibodies from mice engineered with human Ig heavy and light chain YACs","volume":"7","author":"Green","year":"1994","journal-title":"Nat Genet."},{"key":"B84","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1038\/368856a0","article-title":"Antigen-specific human antibodies from mice comprising four distinct genetic modifications","volume":"368","author":"Lonberg","year":"1994","journal-title":"Nature."},{"key":"B85","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1016\/0958-1669(95)80093-X","article-title":"Production of fully human antibodies by transgenic mice","volume":"6","author":"Jakobovits","year":"1995","journal-title":"Curr Opin Biotechnol."},{"key":"B86","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/S0958-1669(02)00354-3","article-title":"Antibody discovery: the use of transgenic mice to generate human monoclonal antibodies for therapeutics","volume":"13","author":"Kellermann","year":"2002","journal-title":"Curr Opin Biotechnol."},{"key":"B87","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/S0022-1759(99)00137-4","article-title":"Antibody engineering via genetic engineering of the mouse: XenoMouse strains are a vehicle for the facile generation of therapeutic human monoclonal antibodies","volume":"231","author":"Green","year":"1999","journal-title":"J Immunol Methods."},{"key":"B88","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1038\/nbt1337","article-title":"From XenoMouse technology to panitumumab, the first fully human antibody product from transgenic mice","volume":"25","author":"Jakobovits","year":"2007","journal-title":"Nat Biotechnol."},{"key":"B89","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1038\/nbt1135","article-title":"Human antibodies from transgenic animals","volume":"23","author":"Lonberg","year":"2005","journal-title":"Nat Biotechnol."},{"key":"B90","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1007\/s00005-014-0322-x","article-title":"Human antibody production in transgenic animals","volume":"63","author":"Br\u00fcggemann","year":"2015","journal-title":"Arch Immunol Ther Exp."},{"key":"B91","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1038\/nbt0697-553","article-title":"Yeast surface display for screening con1binatorial polypeptide libraries","volume":"15","author":"Boder","year":"1997","journal-title":"Nat Biotechnol."},{"key":"B92","doi-asserted-by":"publisher","first-page":"4937","DOI":"10.1073\/pnas.94.10.4937","article-title":"In vitro selection and evolution of functional proteins by using ribosome display","volume":"94","author":"Hanes","year":"1997","journal-title":"Proc Natl Acad Sci USA."},{"key":"B93","doi-asserted-by":"publisher","first-page":"12297","DOI":"10.1073\/pnas.94.23.12297","article-title":"RNA-peptide fusions for the in vitro selection of peptides and proteins","volume":"94","author":"Roberts","year":"1997","journal-title":"Proc Natl Acad Sci USA."},{"key":"B94","doi-asserted-by":"publisher","first-page":"2806","DOI":"10.1073\/pnas.0400219101","article-title":"CIS display: in vitro selection of peptides from libraries of protein-DNA complexes","volume":"101","author":"Odegrip","year":"2004","journal-title":"Proc Natl Acad Sci USA."},{"key":"B95","doi-asserted-by":"publisher","first-page":"9637","DOI":"10.1073\/pnas.0603653103","article-title":"Isolation of anti-CD22 Fv with high affinity by Fv display on human cells","volume":"103","author":"Ho","year":"2006","journal-title":"Proc Natl Acad Sci USA."},{"key":"B96","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.toxicon.2018.03.004","article-title":"Pros and cons of different therapeutic antibody formats for recombinant antivenom development","volume":"146","author":"Laustsen","year":"2018","journal-title":"Toxicon."},{"key":"B97","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.tibtech.2010.03.007","article-title":"Multivalent antibodies: when design surpasses evolution","volume":"28","author":"Cuesta","year":"2010","journal-title":"Trends Biotechnol."},{"key":"B98","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1016\/j.drudis.2015.02.008","article-title":"Bispecific antibodies","volume":"20","author":"Kontermann","year":"2015","journal-title":"Drug Discov Today."},{"key":"B99","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1128\/AAC.01802-15","article-title":"Generation and characterization of ALX-0171, a potent novel therapeutic nanobody for the treatment of respiratory syncytial virus infection","volume":"60","author":"Detalle","year":"2016","journal-title":"Antimicrob Agents Chemother."},{"key":"B100","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1126\/science.aag3267","article-title":"A \u201cTrojan horse\u201d bispecific-antibody strategy for broad protection against ebolaviruses","volume":"354","author":"Wec","year":"2016","journal-title":"Science."},{"key":"B101","doi-asserted-by":"publisher","first-page":"53","DOI":"10.3390\/toxins11010053","article-title":"Toxin neutralization using alternative binding proteins","volume":"11","author":"Jenkins","year":"2019","journal-title":"Toxins."},{"key":"B102","doi-asserted-by":"publisher","first-page":"309","DOI":"10.3390\/toxins10080309","article-title":"Integrating engineering, manufacturing, and regulatory considerations in the development of novel antivenoms","volume":"10","author":"Laustsen","year":"2018","journal-title":"Toxins."},{"key":"B103","doi-asserted-by":"publisher","first-page":"534","DOI":"10.3390\/toxins10120534","article-title":"Biosynthetic oligoclonal antivenom (BOA) for snakebite and next-generation treatments for snakebite victims","volume":"10","author":"Kini","year":"2018","journal-title":"Toxins."},{"key":"B104","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/s40409-017-0127-6","article-title":"Snakebite envenomation turns again into a neglected tropical disease!","volume":"23","author":"Chippaux","year":"2017","journal-title":"J Venom Anim Toxins Trop Dis."},{"key":"B105","doi-asserted-by":"publisher","first-page":"66","DOI":"10.3390\/toxins8030066","article-title":"DNA Aptamers against Taiwan Banded Krait \u03b1-Bungarotoxin recognize Taiwan Cobra Cardiotoxins","volume":"8","author":"Chen","year":"2016","journal-title":"Toxins."},{"key":"B106","doi-asserted-by":"publisher","first-page":"7202","DOI":"10.1038\/s41598-017-07554-5","article-title":"Efficient functional neutralization of lethal peptide toxins in vivo by oligonucleotides","volume":"7","author":"El-Aziz","year":"2017","journal-title":"Sci Rep."},{"key":"B107","doi-asserted-by":"publisher","first-page":"7764","DOI":"10.1166\/jnn.2016.12851","article-title":"C60 Fullerenes as a novel treatment for poisoning and envenomation: a proof-of-concept study for snakebite","volume":"16","author":"Karain","year":"2016","journal-title":"J Nanosci Nanotechnol."},{"key":"B108","volume-title":"Recombinant antivenoms","author":"Laustsen","year":"2016"},{"key":"B109","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.biochi.2014.07.001","article-title":"Heterologous expression and biochemical and functional characterization of a recombinant alpha-type myotoxin inhibitor from Bothrops alternatus snake","volume":"105","author":"Santos-Filho","year":"2014","journal-title":"Biochimie."},{"key":"B110","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.toxicon.2013.10.007","article-title":"Suppression of severe lesions, myonecrosis and hemorrhage, caused by Protobothrops flavoviridis venom with its serum proteins","volume":"76","author":"Chijiwa","year":"2013","journal-title":"Toxicon."},{"key":"B111","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1007\/s10930-012-9392-y","article-title":"High-level expression, purification, characterization and structural prediction of a snake venom metalloproteinase inhibitor in Pichia pastoris","volume":"31","author":"Shi","year":"2012","journal-title":"Protein J."},{"key":"B112","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1016\/j.phymed.2011.02.004","article-title":"The belonging of gpMuc, a glycoprotein from Mucuna pruriens seeds, to the Kunitz-type trypsin inhibitor family explains its direct anti-snake venom activity","volume":"18","author":"Scir\u00e8","year":"2011","journal-title":"Phytomedicine Int J Phytother Phytopharm."},{"key":"B113","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/j.toxicon.2009.02.001","article-title":"Identification and characterization of phospholipase A2 inhibitors from the serum of the Japanese rat snake, Elaphe climacophora","volume":"53","author":"Shirai","year":"2009","journal-title":"Toxicon."},{"key":"B114","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.cbpb.2006.09.003","article-title":"Isolation, characterization and molecular cloning of AnMIP, a new alpha-type phospholipase A2 myotoxin inhibitor from the plasma of the snake Atropoides nummifer (Viperidae: Crotalinae)","volume":"146","author":"Quir\u00f3s","year":"2007","journal-title":"Comp Biochem Physiol B Biochem Mol Biol."},{"key":"B115","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1016\/j.toxicon.2003.08.006","article-title":"PO41, a snake venom metalloproteinase inhibitor isolated from Philander opossum serum","volume":"42","author":"Jurgilas","year":"2003","journal-title":"Toxicon."},{"key":"B116","doi-asserted-by":"publisher","first-page":"13129","DOI":"10.1074\/jbc.M200589200","article-title":"Structural and functional analyses of DM43, a snake venom metalloproteinase inhibitor from Didelphis marsupialis serum","volume":"277","author":"Neves-Ferreira","year":"2002","journal-title":"J Biol Chem."},{"key":"B117","doi-asserted-by":"publisher","first-page":"248","DOI":"10.3390\/toxins8090248","article-title":"Varespladib (LY315920) Appears to be a potent, broad-spectrum, inhibitor of snake venom phospholipase A2 and a possible pre-referral treatment for envenomation","volume":"8","author":"Lewin","year":"2016","journal-title":"Toxins."},{"key":"B118","doi-asserted-by":"publisher","first-page":"380","DOI":"10.3390\/toxins10100380","article-title":"Delayed oral LY333013 rescues mice from highly neurotoxic, lethal doses of Papuan Taipan (Oxyuranus scutellatus) venom","volume":"10","author":"Lewin","year":"2018","journal-title":"Toxins."},{"key":"B119","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.toxicon.2017.04.001","article-title":"Peptidomimetic hydroxamate metalloproteinase inhibitors abrogate local and systemic toxicity induced by Echis ocellatus (saw-scaled) snake venom","volume":"132","author":"Arias","year":"2017","journal-title":"Toxicon."},{"key":"B120","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.toxicon.2018.11.292","article-title":"Neutralizing properties of LY315920 toward snake venom group I and II myotoxic phospholipases A2","volume":"157","author":"Bryan-Quir\u00f3s","year":"2019","journal-title":"Toxicon."},{"key":"B121","doi-asserted-by":"publisher","first-page":"42","DOI":"10.3390\/tropicalmed3020042","article-title":"Recent advances in next generation snakebite antivenoms","volume":"3","author":"Knudsen","year":"2018","journal-title":"Trop Med Infect Dis."},{"key":"B122","first-page":"214","article-title":"Monoclonal antibodies to scorpion toxins. Characterization and molecular mechanisms of neutralization","volume":"141","author":"Bahraoui","year":"1988","journal-title":"J Immunol Baltim Md. 1950"},{"key":"B123","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1016\/j.toxicon.2010.07.014","article-title":"Immunochemical and biological characterization of monoclonal antibodies against BaP1, a metalloproteinase from Bothrops asper snake venom","volume":"56","author":"Fernandes","year":"2010","journal-title":"Toxicon."},{"key":"B124","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.toxicon.2013.05.005","article-title":"Bothropic antivenom based on monoclonal antibodies, is it possible?","volume":"71","author":"Frauches","year":"2013","journal-title":"Toxicon."},{"key":"B125","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.toxicon.2007.10.009","article-title":"Neutralization of hemorrhagic snake venom metalloproteinase HR1a from Protobothrops flavoviridis. by human monoclonal antibody","volume":"51","author":"Morine","year":"2008","journal-title":"Toxicon"},{"key":"B126","doi-asserted-by":"publisher","first-page":"1969","DOI":"10.1016\/0006-2952(95)02095-0","article-title":"Specificity and binding affinity of an anti-crotoxin combinatorial antibody selected from a phage-displayed library","volume":"50","author":"Meng","year":"1995","journal-title":"Biochem Pharmacol."},{"key":"B127","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/j.toxicon.2007.11.014","article-title":"Monoclonal antibody fragment from combinatorial phage display library neutralizes alpha-latrotoxin activity and abolishes black widow spider venom lethality, in mice","volume":"51","author":"Bugli","year":"2008","journal-title":"Toxicon."},{"key":"B128","doi-asserted-by":"publisher","first-page":"173","DOI":"10.3109\/1547691X.2011.649220","article-title":"Serrumab: a human monoclonal antibody that counters the biochemical and immunological effects of Tityus serrulatus venom","volume":"9","author":"Pucca","year":"2012","journal-title":"J Immunotoxicol."},{"key":"B129","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1111\/j.1742-7843.2011.00821.x","article-title":"Production of human antibody fragments binding to melittin and phospholipase A2 in Africanised bee venom: minimising venom toxicity","volume":"110","author":"Funayama","year":"2012","journal-title":"Basic Clin Pharmacol Toxicol."},{"key":"B130","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1016\/j.toxicon.2006.11.023","article-title":"Isolation, characterization and pentamerization of alpha-cobrotoxin specific single-domain antibodies from a na\u00efve phage display library: preliminary findings for antivenom development","volume":"49","author":"Stewart","year":"2007","journal-title":"Toxicon."},{"key":"B131","doi-asserted-by":"publisher","first-page":"e69495","DOI":"10.1371\/journal.pone.0069495","article-title":"In vivo neutralization of \u03b1-cobratoxin with high-affinity llama single-domain antibodies (VHHs) and a VHH-Fc antibody","volume":"8","author":"Richard","year":"2013","journal-title":"PLoS ONE."},{"key":"B132","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/S1380-2933(97)00068-7","article-title":"Biologically active human anti-crotoxin scFv isolated from a semi-synthetic phage library","volume":"3","author":"Lafaye","year":"1997","journal-title":"Immunotechnology."},{"key":"B133","doi-asserted-by":"publisher","first-page":"2591","DOI":"10.1111\/j.1742-4658.2005.04687.x","article-title":"A strategy for the generation of specific human antibodies by directed evolution and phage display. An example of a single-chain antibody fragment that neutralizes a major component of scorpion venom","volume":"272","author":"Ria\u00f1o-Umbarila","year":"2005","journal-title":"FEBS J."},{"key":"B134","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1016\/j.bbagen.2006.04.008","article-title":"Expression of recombinant human antibody fragments capable of inhibiting the phospholipase and myotoxic activities of Bothrops jararacussu venom","volume":"1760","author":"Tamarozzi","year":"2006","journal-title":"Biochim Biophys Acta."},{"key":"B135","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.jprot.2008.12.007","article-title":"Human monoclonal ScFv neutralize lethal Thai cobra, Naja kaouthia, neurotoxin","volume":"72","author":"Kulkeaw","year":"2009","journal-title":"J Proteomics."},{"key":"B136","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.actatropica.2017.09.001","article-title":"Discovery of human scFvs that cross-neutralize the toxic effects of B. jararacussu and C. d. terrificus venoms","volume":"177","author":"Silva","year":"2018","journal-title":"Acta Trop."},{"key":"B137","doi-asserted-by":"publisher","first-page":"133","DOI":"10.3109\/1547691X.2013.809175","article-title":"Serrumab: a novel human single chain-fragment antibody with multiple scorpion toxin-neutralizing capacities","volume":"11","author":"Pucca","year":"2014","journal-title":"J Immunotoxicol."},{"key":"B138","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.toxicon.2016.01.062","article-title":"Human scFv antibodies (Afribumabs) against Africanized bee venom: advances in melittin recognition","volume":"112","author":"Pessenda","year":"2016","journal-title":"Toxicon."},{"key":"B139","doi-asserted-by":"publisher","first-page":"3928","DOI":"10.1038\/s41467-018-06086-4","article-title":"In vivo neutralization of dendrotoxin-mediated neurotoxicity of black mamba venom by oligoclonal human IgG antibodies","volume":"9","author":"Laustsen","year":"2018","journal-title":"Nat Commun."},{"key":"B140","doi-asserted-by":"publisher","first-page":"393","DOI":"10.3390\/toxins10100393","article-title":"Antibody cross-reactivity in antivenom research","volume":"10","author":"Ledsgaard","year":"2018","journal-title":"Toxins."},{"key":"B141","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.toxicon.2018.05.021","article-title":"Toxin-centric development approach for next-generation antivenoms","volume":"150","author":"Laustsen","year":"2018","journal-title":"Toxicon."},{"key":"B142","doi-asserted-by":"publisher","first-page":"e0005361","DOI":"10.1371\/journal.pntd.0005361","article-title":"Recombinant snakebite antivenoms: a cost-competitive solution to a neglected tropical disease?","volume":"11","author":"Laustsen","year":"2017","journal-title":"PLoS Negl Trop Dis."},{"key":"B143","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.toxicon.2015.03.001","article-title":"Snake venomics of monocled cobra (Naja kaouthia) and investigation of human IgG response against venom toxins","volume":"99","author":"Laustsen","year":"2015","journal-title":"Toxicon."},{"key":"B144","doi-asserted-by":"publisher","first-page":"160","DOI":"10.3109\/1547691X.2012.703253","article-title":"Human antibody fragments specific for Bothrops jararacussu venom reduce the toxicity of other Bothrops sp. venoms","volume":"10","author":"Roncolato","year":"2013","journal-title":"J Immunotoxicol."},{"key":"B145","doi-asserted-by":"publisher","first-page":"32","DOI":"10.3390\/toxins11010032","article-title":"Generation of a broadly cross-neutralizing antibody fragment against several mexican scorpion venoms","volume":"11","author":"Ria\u00f1o-Umbarila","year":"2019","journal-title":"Toxins."},{"key":"B146","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.toxicon.2015.07.334","article-title":"Selecting key toxins for focused development of elapid snake antivenoms and inhibitors guided by a Toxicity Score","volume":"104","author":"Laustsen","year":"2015","journal-title":"Toxicon."},{"key":"B147","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1080\/15569543.2016.1220397","article-title":"Toxin synergism in snake venoms","volume":"35","author":"Laustsen","year":"2016","journal-title":"Toxin Rev."},{"key":"B148","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.toxlet.2018.02.004","article-title":"Synergistic strategies of predominant toxins in snake venoms","volume":"287","author":"Xiong","year":"2018","journal-title":"Toxicol Lett."},{"key":"B149","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.toxicon.2019.06.005","article-title":"Engineering and design considerations for next-generation snakebite antivenoms","volume":"167","author":"Knudsen","year":"2019","journal-title":"Toxicon."}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2019.01598\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,23]],"date-time":"2019-09-23T10:40:33Z","timestamp":1569235233000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2019.01598\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,10]]},"references-count":149,"alternative-id":["10.3389\/fimmu.2019.01598"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2019.01598","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,10]]},"article-number":"1598"}}